Fulgent Genetics, Inc. FLGT Investing Cash Flow
Investing Cash Flow at other companies
Other financials
Where this comes from
Reported directly by Fulgent Genetics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:NetCashProvidedByUsedInInvestingActivities.
The official record: Fulgent Genetics, Inc.’s 10-Q, filed May 1, 2026, on SEC EDGAR. View the filing →
Ask your AI about Fulgent Genetics, Inc.'s investing cash flow.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Fulgent Genetics, Inc.'s investing cash flow?
- Fulgent Genetics, Inc. (FLGT) reported investing cash flow of $10.94M in Q1 2026.
- How has Fulgent Genetics, Inc.'s investing cash flow changed year-over-year?
- Fulgent Genetics, Inc.'s investing cash flow decreased by 60.6% year-over-year, from $27.73M to $10.94M.
- What is the long-term trend for Fulgent Genetics, Inc.'s investing cash flow?
- Over 2 years (2021 to 2025), Fulgent Genetics, Inc.'s investing cash flow has grown at a -54.9% compound annual growth rate (CAGR), from -$546.55M to $111.37M.
- What does investing cash flow mean?
- Total net cash provided by or used in investing activities — capex, acquisitions, investment purchases/sales, and other investing items.